These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33099376)

  • 21. An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review.
    Xia E; Li SJ; Drake L; Reyes-Hadsall S; Mita C; Drucker AM; Mostaghimi A
    J Invest Dermatol; 2023 Jul; 143(7):1133-1137.e12. PubMed ID: 37115113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating Alopecia Areata: Current Practices Versus New Directions.
    Gupta AK; Carviel J; Abramovits W
    Am J Clin Dermatol; 2017 Feb; 18(1):67-75. PubMed ID: 27770310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel therapeutic paradigm for patients with extensive alopecia areata.
    Renert-Yuval Y; Guttman-Yassky E
    Expert Opin Biol Ther; 2016 Aug; 16(8):1005-14. PubMed ID: 27164008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eyebrows Are Important in the Treatment of Alopecia Areata.
    Liu LY; King BA; Ko JM
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S37-S40. PubMed ID: 33099382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for alopecia areata.
    Delamere FM; Sladden MM; Dobbins HM; Leonardi-Bee J
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004413. PubMed ID: 18425901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.
    Lee K; Woodbury MJ; Zundell MP; Aguero R; Yousif J; Williams SC; Rosmarin D; Silverberg N; Thiboutot D; Larocca C; Shinohara MM; Mostaghimi A; Stander S; Martorell A; Jaleel T; Torbeck RL; Siegel DM; Perez-Chada L; Strand V; Armstrong AW; Merola JF; Gottlieb AB
    J Drugs Dermatol; 2023 Dec; 22(12):1153-1159. PubMed ID: 38051841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting.
    Perez-Chada LM; Merola JF; Armstrong AW; Gottlieb AB
    J Rheumatol Suppl; 2020 Jun; 96():36-40. PubMed ID: 32482766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
    Ramot Y; Zlotogorski A
    Harefuah; 2020 Jan; 159(1):38-42. PubMed ID: 31930807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series.
    Ekelem C; Juhasz M; Yu J; Hosking AM; Csuka E; Choi F; Pham CT; Heidari AE; Valdebran M; Rapaport JA; Chen Z; Mesinkovska NA
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S50-S54. PubMed ID: 33099385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of alopecia areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between alopecia areata, psoriasis vulgaris, thyroid disease, and metabolic syndrome.
    Ishak RS; Piliang MP
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S56-7. PubMed ID: 24326560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.
    Malik K; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.
    Bain KA; McDonald E; Moffat F; Tutino M; Castelino M; Barton A; Cavanagh J; Ijaz UZ; Siebert S; McInnes IB; Astrand A; Holmes S; Milling SWF
    Br J Dermatol; 2020 Jan; 182(1):130-137. PubMed ID: 30980732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic alopecia.
    George SM; Taylor MR; Farrant PB
    Clin Exp Dermatol; 2015 Oct; 40(7):717-21. PubMed ID: 26202646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alopecia areata update.
    Alkhalifah A
    Dermatol Clin; 2013 Jan; 31(1):93-108. PubMed ID: 23159179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label studies on apremilast in dermatology: a review.
    Maloney NJ; Zhao J; Tegtmeyer K; Lee EY; Cheng K
    J Dermatolog Treat; 2020 Mar; 31(2):131-140. PubMed ID: 30935262
    [No Abstract]   [Full Text] [Related]  

  • 37. Co-localization of alopecia areata and lichen planopilaris in a patient receiving immunosuppressants: A rare case.
    Mofarrah R; Mofarrah R; Jahani Amiri K; Ghasemi M
    J Cosmet Dermatol; 2021 Mar; 20(3):976-979. PubMed ID: 33167077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementary and alternative medicine in alopecia areata.
    van den Biggelaar FJ; Smolders J; Jansen JF
    Am J Clin Dermatol; 2010; 11(1):11-20. PubMed ID: 20000871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of alopecia areata: An Australian expert consensus statement.
    Cranwell WC; Lai VW; Photiou L; Meah N; Wall D; Rathnayake D; Joseph S; Chitreddy V; Gunatheesan S; Sindhu K; Sharma P; Green J; Eisman S; Yip L; Jones L; Sinclair R
    Australas J Dermatol; 2019 May; 60(2):163-170. PubMed ID: 30411329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.